Evidence map›Paper›PMID 41520045›Full record

ArticleApplied microbiology and biotechnology2026

The phage shock protein response of Listeria monocytogenes influences tolerance to the multipeptide bacteriocin garvicin KS.

Thomas F Oftedal, Trond Løvdal, Morten Kjos

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas F OftedalFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway. thof@nmbu.no.
Trond LøvdalDepartment of Process Technology, NOFIMA-Norwegian Institute of Food, Fisheries and Aquaculture Research, Stavanger, Norway.
Morten KjosFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway.

Funding

Norges Forskningsråd 341639
6 · The paper itself

Abstract

Food waste due to perishable and unsafe food products is a major issue worldwide. For some high-quality perishable food products, such as fresh fish and cold-smoked salmon, traditional food preservation techniques are unsuitable as they can compromise sensory qualities such as flavor, texture, and freshness. These products often support the growth of the human pathogen Listeria monocytogenes, which can be present if thermal treatment is not applied. Thus, antilisterial bacteriocins, such as garvicin KS (GarKS), in combination with other technologies like high-pressure processing, are being investigated as hurdle strategies to increase the shelf life and food safety of fish products. In this study, we aimed to identify potential resistance development and genetic factors affecting the susceptibility of L. monocytogenes towards GarKS. We show that L. monocytogenes strains associated with fish products and fish processing plants are susceptible to GarKS with MIC values ranging from 20 to 275 nM. By RNA sequencing, we showed that exposure to GarKS resulted in an upregulation of genes involved in the phage shock protein (psp) response. Furthermore, isolation of resistant mutants indicated a low frequency of resistance to GarKS (10⁻

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBacteriocinsDrug Resistance, BacterialHeat-Shock ProteinsListeria monocytogenesAnimalsFish ProductsFood MicrobiologyFood PreservationMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsBacteriocinsHeat-Shock Proteinsphage shock protein, BacteriaAntimicrobial resistanceBacteriocinFood conservationHurdle technologyListeriaPhage shock protein

Identifiers

PMID41520045
PMCPMC12791056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.